{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:37:58Z","timestamp":1790372278395,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T00:00:00Z","timestamp":1696723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.radcr.2023.10.024","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T12:36:27Z","timestamp":1699274187000},"page":"305-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Complete metabolic response after Partially Ablative Radiotherapy (PAR) for bulky retroperitoneal liposarcoma: A case report"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7867-8987","authenticated-orcid":false,"given":"Federica","family":"Medici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Strolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savino","family":"Cilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Laghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Galietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7873-5072","authenticated-orcid":false,"given":"Maria","family":"Vadal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Strigari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio Giuseppe","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2111-0164","authenticated-orcid":false,"given":"Silvia","family":"Cammelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radcr.2023.10.024_bib0001","unstructured":"WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. [accessed July 6.07.23]. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/Soft-Tissue-And-Bone-Tumours-2020"},{"issue":"5 Suppl","key":"10.1016\/j.radcr.2023.10.024_bib0002","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.annpat.2012.07.014","article-title":"Contribution of molecular biology for better management of soft tissue tumors","volume":"32","author":"Neuville","year":"2012","journal-title":"Ann Pathol"},{"issue":"5 Suppl","key":"10.1016\/j.radcr.2023.10.024_bib0003","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.annpat.2012.07.004","article-title":"Liposarcomas","volume":"32","author":"Terrier","year":"2012","journal-title":"Ann Pathol"},{"issue":"Suppl 3","key":"10.1016\/j.radcr.2023.10.024_bib0004","article-title":"Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","year":"2014","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.radcr.2023.10.024_bib0005","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.radcr.2023.10.024_bib0006","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/ejso.2000.1057","article-title":"Soft tissue carcinoma in the retroperitoneum: an often neglected diagnosis","volume":"27","author":"van Dalus","year":"2001","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.radcr.2023.10.024_bib0007","doi-asserted-by":"crossref","first-page":"79","DOI":"10.21037\/cco-20-209","article-title":"A critical narrative review of radiotherapy for retroperitoneal soft tissue sarcoma","volume":"9","author":"Fevre","year":"2020","journal-title":"Chin Clin Oncol"},{"issue":"3","key":"10.1016\/j.radcr.2023.10.024_bib0008","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ijrobp.2005.03.004","article-title":"Results of radiation therapy for unresected soft-tissue sarcomas","volume":"63","author":"Kepka","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radcr.2023.10.024_bib0009","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13569-016-0060-4","article-title":"UK guidelines for the management of soft tissue sarcomas","volume":"6","author":"Dangoor","year":"2016","journal-title":"Clin Sarcoma Res"},{"issue":"6","key":"10.1016\/j.radcr.2023.10.024_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/acm2.12427","article-title":"Partially ablative radiotherapy (PAR) for large mass tumors using simultaneous integrated boost: a dose-escalation feasibility study","volume":"19","author":"Cilla","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radcr.2023.10.024_bib0011","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"3 Suppl","key":"10.1016\/j.radcr.2023.10.024_bib0012","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ijrobp.2009.07.1754","article-title":"Use of normal tissue complication probability models in the clinic","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.radcr.2023.10.024_bib0013","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.21873\/anticanres.13585","article-title":"Palliative Short-course radiotherapy in advanced pelvic cancer: a phase II study (SHARON Project)","volume":"39","author":"Farina","year":"2019","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.radcr.2023.10.024_bib0014","doi-asserted-by":"crossref","first-page":"20978","DOI":"10.1038\/s41598-022-25602-7","article-title":"Short course palliative radiotherapy in advanced solid tumors: a pooled analysis (the SHARON project)","volume":"12","author":"Donati","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.radcr.2023.10.024_bib0015","doi-asserted-by":"crossref","first-page":"823445","DOI":"10.3389\/fonc.2022.823445","article-title":"A \u201cSHort course Accelerated RadiatiON therapy\u201d (SHARON) During and Beyond the COVID-19 Pandemic","volume":"12","author":"Morganti","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.radcr.2023.10.024_bib0016","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00066-022-01976-5","article-title":"The tumor core boost study: a feasibility study of radical dose escalation to the central part of large tumors with an integrated boost in the palliative treatment setting","volume":"199","author":"Wittenstein","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radcr.2023.10.024_bib0017","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820983028","article-title":"Definitive radiotherapy in the management of non-resectable or residual retroperitoneal sarcomas: institutional cohort analysis and systematic review","volume":"28","author":"Sobiborowicz","year":"2021","journal-title":"Cancer Control"},{"issue":"5","key":"10.1016\/j.radcr.2023.10.024_bib0018","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.ijrobp.2011.01.065","article-title":"High-dose spatially fractionated GRID radiation therapy (SFGRT): a comparison of treatment outcomes with CERROBEND vs","volume":"82","author":"Neuner","year":"2012","journal-title":"MLC SFGRT. Int J Radiat Oncol"},{"issue":"6","key":"10.1016\/j.radcr.2023.10.024_bib0019","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1667\/RADE-20-00100.1","article-title":"Spatially fractionated radiotherapy (GRID) prior to standard neoadjuvant conventionally fractionated radiotherapy for bulky, high-risk soft tissue and osteosarcomas: feasibility, safety, and promising pathologic response rates","volume":"194","author":"Snider","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.radcr.2023.10.024_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.phro.2022.04.010","article-title":"Physical aspects of a spatially fractionated radiotherapy technique for large soft tissue sarcomas","volume":"22","author":"Borzov","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radcr.2023.10.024_bib0021","series-title":"Clinical radiation oncology","author":"Gunderson","year":"2007"},{"issue":"6","key":"10.1016\/j.radcr.2023.10.024_bib0022","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1667\/RADE-20-00066.1","article-title":"The technical and Clinical implementation of LATTICE radiation therapy (LRT)","volume":"194","author":"Wu","year":"2020","journal-title":"Radiat Res"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043323007690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043323007690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:03:41Z","timestamp":1761825821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1930043323007690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1930043323007690"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2023.10.024","relation":{},"ISSN":["1930-0433"],"issn-type":[{"value":"1930-0433","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete metabolic response after Partially Ablative Radiotherapy (PAR) for bulky retroperitoneal liposarcoma: A case report","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2023.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}